(Q36478823)

14 August 2017

1 reference

title

Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond (English)

1 reference

14 August 2017

0 references

1 reference

David W Stepp

1

1 reference

PubMed ID

16700872

14 August 2017

language of work or name

1 reference

1 May 2006

1 reference

Clinical and Experimental Pharmacology and Physiology

14 August 2017

1 reference

14 August 2017

33

1 reference

14 August 2017

5-6

1 reference

14 August 2017

407-414

1 reference

Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Blood pressure levels in the 41 populations of the WHO MONICA Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Mechanisms of hypertension and kidney disease in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

New risk factors for atherosclerosis and patient risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Low-flow vascular remodeling in the metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Active role for the vasculature in the delivery of insulin to skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Role of blood flow in the regulation of muscle glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Control of the forearm microcirculation: interactions with measures of obesity and noradrenaline kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Investigation of basal endothelial function in the obese Zucker rat in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Impaired nitric oxide function in the basilar artery of the obese Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Altered pressure-natriuresis in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Altered renal microvascular response in Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Increased vascular endothelin-1 gene expression with unaltered nitric oxide synthase levels in fructose-induced hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Vascular NADPH oxidases: molecular mechanisms of activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Reactive oxygen species in vascular biology: implications in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Investigation of oxidant stress and vasodepression to glyceryl trinitrate in the obese Zucker rat in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Role of reactive oxygen species in endothelin-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Endothelin, angiotensin, and oxidative stress in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

What is new in endothelium-derived hyperpolarizing factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

EDHF-mediated relaxation is impaired in fructose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Potassium (BK(Ca)) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Alterations in KATP and KCa channel function in cerebral arteries of insulin-resistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Obesity and hypertension: two epidemics or one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Moderately obese, insulin-resistant women exhibit abnormal vascular reactivity to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Impaired skeletal muscle and skin microcirculatory function in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Modulation of noradrenaline-induced vasoconstriction in isolated perfused mesenteric arterial beds from obese Zucker rats in the presence and absence of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Vascular response to angiotensin II in upper body obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04381.X

10.1111/J.1440-1681.2006.04381.X

21 January 2018

Identifiers

DOI

1 reference

release_5d4e5etnzrfovdliadzleojysy

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5d4e5etnzrfovdliadzleojysy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16700872

1 reference

PubMed ID

16700872